Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire HKSTP Elite Global Inno Day Showcasing Impactful Innovations from Future Unicorns
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Acquisition of Three High-Quality Assets Drive Diversified Business Development for Goldstream Investment
Party Central Committee concludes 13th Conference with major resolutions for reform and national development 2.